Results 111 to 120 of about 18,985 (204)
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid
peer reviewedBisphosphonate drugs inhibit osteoclastic bone resorption and are widely used to treat skeletal complications in patients with tumor-induced osteolysis.
Bonjean, Karine +7 more
core +1 more source
Zoledronic acid for chronic kidney disease-associated osteoporosis. [PDF]
Sakthivel S +4 more
europepmc +1 more source
Chen Shi,1,* Mi Zhang,2,* An-Yuan Cheng,1 Zi-Feng Huang1 1Department of Trauma Surgery, Wuhan No 1 Hospital, Wuhan, China; 2Department of Orthopedics, Wuhan No 5 Hospital, Wuhan, China *These authors contributed equally to this work Objective: We
Cheng AY, Shi C, Zhang M, Huang ZF
core
Zoledronic Acid in the Management of Melorheostosis of Radius and Ulna - A Rare Case Report with Literature Review. [PDF]
Mallya S, Das R, Boruah DK, Puranik A.
europepmc +1 more source
Pseudogout attack following zoledronic acid treatment in primary hyperparathyroidism. [PDF]
Emur Gunay Y, Gunay M.
europepmc +1 more source
Bisphosphonate (Zoledronic Acid) Associated Adverse Events: Single Center Experience
Zoledronic acid is an efficacy-proven bisphosphonate used in the patients who develop bone metastasis. In our study, we planned to evaluate side effects occurring in the patients who receive zoledronic acid.
Uslu, Ruchan +8 more
core
Zoledronic Acid-Induced Orbital Inflammation: A Diagnostic Challenge. [PDF]
Nasrini T, Bacon A, Umesh S.
europepmc +1 more source
Fanconi syndrome induced by zoledronic acid: Two case reports. [PDF]
Chen Y +5 more
europepmc +1 more source
TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis. [PDF]
Liu Y +6 more
europepmc +1 more source

